Skip to content

NovoCure Limited: filings

Every NovoCure Limited annual and quarterly report in the SEC record with the published financial measures it tagged, 46 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-07-23fiscal Q2 2026411650001645113-26-000062
10-Q2026-04-30fiscal Q1 2026411110001645113-26-000042
10-K2026-02-26fiscal FY 2025501330001645113-26-000017
10-Q2025-10-30fiscal Q3 2025421710001645113-25-000042
10-Q2025-07-24fiscal Q2 2025421670001645113-25-000029
10-Q2025-04-24fiscal Q1 2025421130001645113-25-000008
10-K2025-02-27fiscal FY 2024511350001645113-25-000002
10-Q2024-10-30fiscal Q3 2024421710001645113-24-000031
10-Q2024-07-25fiscal Q2 2024421670001645113-24-000019
10-Q2024-05-02fiscal Q1 2024421130001645113-24-000013
10-K2024-02-22fiscal FY 2023521370001645113-24-000006
10-Q2023-10-26fiscal Q3 2023421750001645113-23-000047
10-Q2023-07-27fiscal Q2 2023421690001645113-23-000044
10-Q2023-05-04fiscal Q1 2023421130001645113-23-000037
10-K2023-02-23fiscal FY 2022522330001645113-23-000023
10-Q2022-10-27fiscal Q3 2022421730001645113-22-000091
10-Q2022-07-28fiscal Q2 2022421690001645113-22-000067
10-Q2022-04-28fiscal Q1 2022421130001645113-22-000043
10-K2022-02-24fiscal FY 2021522330001645113-22-000011
10-Q2021-10-28fiscal Q3 2021421730001645113-21-000112
10-Q2021-07-29fiscal Q2 2021421690001645113-21-000092
10-Q2021-04-29fiscal Q1 2021431160001645113-21-000061
10-K2021-02-25fiscal FY 2020522170001645113-21-000017
10-Q2020-10-29fiscal Q3 2020421730001645113-20-000155
10-Q/A2020-10-02fiscal Q1 2020421130001645113-20-000150
10-Q/A2020-10-02fiscal Q2 2020421690001645113-20-000148
10-Q2020-07-30fiscal Q2 2020421690001645113-20-000105
10-Q2020-04-30fiscal Q1 2020421130001645113-20-000068
10-K2020-02-27fiscal FY 2019511850001645113-20-000025
10-Q2019-10-31fiscal Q3 2019431740001628280-19-012887
10-Q2019-07-25fiscal Q2 2019391500001564590-19-025954
10-Q2019-05-02fiscal Q1 2019391000001564590-19-015011
10-K2019-02-28fiscal FY 2018441650001564590-19-005146
10-Q2018-10-25fiscal Q3 2018371390001564590-18-024994
10-Q2018-07-26fiscal Q2 2018371410001564590-18-017498
10-Q2018-04-26fiscal Q1 201832800001564590-18-009158
10-K2018-02-22fiscal FY 2017391240001564590-18-002766
10-Q2017-10-26fiscal Q3 2017311100001564590-17-020089
10-Q2017-07-27fiscal Q2 2017311110001564590-17-014164
10-Q2017-04-27fiscal Q1 201731780001564590-17-007412
10-K2017-02-23fiscal FY 2016391220001564590-17-002097
10-Q2016-11-02fiscal Q3 2016301070001564590-16-026833
10-Q2016-07-28fiscal Q2 2016301080001564590-16-021602
10-Q2016-05-10fiscal Q1 201630770001564590-16-018739
10-K2016-03-01fiscal FY 201536920001564590-16-013777
10-Q2015-10-27fiscal Q3 201528780001564590-15-008641

Inspect the source

Entity
NovoCure Limited / CIK 0001645113
Captured
2026-09-21T17:23:10.879Z
SEC response SHA-256
341f267dfdfd4e13271c12e8417a069d35bde3287b9036eee37c7d8e5e7e91f9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001645113.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))